| Literature DB >> 597707 |
A G Turner, W F Hendry, G B Williams, H J Bloom.
Abstract
61 patients with advanced bladder cancer were treated with methotrexate. 3 different regimes were used, 2 given on an out-patient and 1 on an in-patient basis. A response rate of 56% was found in patients who received 100 mg of methotrexate intravenously every 2 weeks as an out-patient. Provided that renal function is checked before therapy and is normal, then methotrexate can be used safely; it being well tolerated and having few serious side-effects.Entities:
Mesh：
Substances：
Year: 1977 PMID： 597707 DOI： 10.1111/j.1464-410x.1977.tb04551.x
Source DB: PubMed Journal: Br J Urol ISSN： 0007-1331